Full Year 2025 Ramsay Health Care Ltd Earnings Call Transcript
Key Points
- Ramsay Health Care Ltd (RMSYF) reported a 6.7% increase in revenue driven by activity increases in both Australian and UK regions.
- The company completed all major private health insurer negotiations, securing improved revenue indexation for FY25 and FY26.
- The performance acceleration team delivered enhanced data insights, resulting in a 3-percentage-point improvement in theater utilization nationwide.
- Ramsay Health Care Ltd (RMSYF) maintained high patient Net Promoter Scores (NPS) and clinical excellence across the group.
- The company implemented a new streamlined group operating model to support its Australia 2030 strategy, including key executive appointments to enhance execution capability.
- Ramsay Health Care Ltd (RMSYF) reported a net profit after tax of only $24 million, impacted by non-recurring items.
- The Joondalup public campus performance is expected to be lower due to a new funding mechanism not keeping up with inflation, with an estimated negative annual impact of $37 million on EBIT.
- Elysium's performance was disappointing due to lower-than-forecast occupancy and significant cost pressures, resulting in a decline in underlying EBIT.
- Ramsay Santé faced challenges with tariffs not reflecting inflation, impacting earnings, and ongoing political and economic uncertainties in France.
- The company experienced higher funding costs in Ramsay Santé and a higher effective tax rate, affecting overall financial performance.
Good morning, and welcome to Ramsay Healthcare's financial results for the 12 months to June 30, 2025. My name is Natalie Davis, and I'm joined today by our acting CFO, Mike Hirner.
Having committed at the half year results to take decisive action to improve performance, accelerate transformation and boost returns, I'm pleased to report that we're making good progress in our multiyear transformation. At our half year results in February, I outlined my priorities for the business, and our progress against these priorities is shown on slide 5.
In our market-leading Australia hospital business, we've been focused on driving top line growth and operational efficiency. We have completed all major private health insurer negotiations and agreed improved revenue indexation for FY25 and 26.
Our performance acceleration team has delivered enhanced data insights to help us make better data-driven decisions faster to grow admissions and improve seat utilization. In Q4 FY25, this supported a 3-percentage
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
